Class D · 2 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Apr 1988
ISIN SE0024788731
BenchmarkMSCI World Health Care · Net
About the fund
The fund
SEB Läkemedelsfond has a history going back to 1988. The management company is SEB Investment Management, legally SEB Funds AB since March 2025. It is wholly owned by the banking group SEB (Skandinaviska Enskilda Banken), headquartered in Stockholm. Day-to-day portfolio management is delegated to SEB Asset Management AB.
Investment philosophy
The fund invests across pharmaceuticals, biotechnology, medical technology and health care services. Sustainability analysis is integrated into investment decisions, and companies, business models and products judged to affect climate, society or stakeholders negatively are excluded.
The managers
The fund is managed by one person, Angelica Fatouros in Stockholm, who has managed it since February 2021, when she also became head of SEB's fundamental equity team. She holds a doctorate in pharmaceutical sciences and has long experience as an analyst in the pharmaceutical industry. She also manages SEB Bioteknikfond.
The portfolio
The active share is somewhat lower than that of comparable funds, so the portfolio sits closer to the sector index. The lasting top positions are large, established companies such as Eli Lilly, Merck, Johnson & Johnson and Thermo Fisher Scientific, across pharmaceuticals, medical devices and health services.
FundTelligence description · 18/10/2026
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.
7 of 18 funds ranked on a calculated return
#11/ 18Year to date
+5.13% NOK
as of 13 Nov 2026 · Converted from SEK to NOK
About the figures
13 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#13/ 221 year
+8.92% NOK
as of 13 Nov 2026 · Converted from SEK to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#4/ 223 years (ann.)
+10.14% NOK
as of 13 Nov 2026 · Converted from SEK to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#4/ 225 years (ann.)
+8.54% NOK
as of 13 Nov 2026 · Converted from SEK to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
Comparison basis
Year to date
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
1 year
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
3 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
5 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.